Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Home > Science Hub > Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time
Back to the list

July 25, 2022

Dhondt B et al. World Journal of Urology 2018

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Dhondt_World J of Urology_2018

Download publication

You might also be interested by

News

Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement

February 3, 2026

More info

CellTalk Blog

This is SPARTA: A Framework for Multiplex Immunofluorescence Analysis

November 13, 2025

More info

Posters

Artificial Intelligence-powered Spatial Analysis of Tumor Microenvironment Identifies Immune Phenotype in Non- Small Cell Lung Cancer, Colorectal Cancer and Urothelial Cancer.

October 30, 2025

More info

Posters

Combining high-plex proteomics with single-cell transcriptomics for deep characterization of antigen-specific T cell responses

October 30, 2025

More info